Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEB trial: BeEAM versus BEAM conditioning before autologous stem cell transplantation in lymphoma
2014-003629-16Phase 2Completed
- Sponsor
- University Hospital/Inselspital Berne, Department for Medical Oncology
- Start
- Jan 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bendamustine, carmustine, cytarabine, etoposide and melphalan in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and mantle cell lymphoma (MCL) (2 arms), sponsored by University Hospital/Inselspital Berne, Department for Medical Oncology. Started Jan 2015; status: completed.
02
Drugs
bendamustinecarmustinecytarabineetoposidemelphalan
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2014-003629-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003629-16.